Darwin EU study: Background incidence rates of selected vaccine adverse events of special in Europe
Minutes of the CAT meeting 21-23 January 2026
Annual report on the use of the special contribution for orphan medicinal products - 2025
Questions and answers on the use of out-of-specification batches of authorised cell and tissue-based advanced therapy medicinal products
Consolidated 3-year work plan for the clinical domain
Scientific advice and protocol assistance adopted during the CHMP meeting 23-26 February 2026
EMA/PE/0000228283
Ifosfamide
Cyclophosphamide
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 20 January 2026, 09:30 (CET) to 20 January 2026, 13:00 (CET)